Works matching IS 03065251 AND DT 1992 AND VI 34 AND IP 3
1
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 3, p. 207, doi. 10.1111/j.1365-2125.1992.tb04126.x
- Duranteau, J;
- Pussard, E;
- Edouard, A;
- Samii, K;
- Berdeaux, A;
- Giudicelli, JF
- Article
2
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 3, p. 272, doi. 10.1111/j.1365-2125.1992.tb04137.x
- Bridges, AB;
- Pringle, TH;
- McNeill, GP;
- Tavendale, R;
- Belch, JJ
- Article
3
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 3, p. 250, doi. 10.1111/j.1365-2125.1992.tb04132.x
- Article
4
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 3, p. 224, doi. 10.1111/j.1365-2125.1992.tb04128.x
- Demolis, P;
- Chalon, S;
- Annane, D;
- Duhaze, P;
- Giudicelli, JF
- Article
5
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 3, p. 199, doi. 10.1111/j.1365-2125.1992.tb04125.x
- Article
6
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 3, p. 244, doi. 10.1111/j.1365-2125.1992.tb04131.x
- Coleman, MD;
- Rhodes, LE;
- Scott, AK;
- Verbov, JL;
- Friedmann, PS;
- Breckenridge, AM;
- Park, BK
- Article
7
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 3, p. 189, doi. 10.1111/j.1365-2125.1992.tb04124.x
- Article
8
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 3, p. 266, doi. 10.1111/j.1365-2125.1992.tb04135.x
- Thomas, VE;
- O'Connell, F;
- Harrison, AJ;
- Fuller, RW
- Article
9
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 3, p. 269, doi. 10.1111/j.1365-2125.1992.tb04136.x
- Article
10
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 3, p. 231, doi. 10.1111/j.1365-2125.1992.tb04129.x
- Ferrara, SD;
- Zotti, S;
- Tedeschi, L;
- Frison, G;
- Castagna, F;
- Gallimberti, L;
- Gessa, GL;
- Palatini, P
- Article
11
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 3, p. 278, doi. 10.1111/j.1365-2125.1992.tb04139.x
- Mushambi, MC;
- Trotter, TN;
- Barker, P;
- Rowbotham, DJ
- Article
12
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 3, p. 262, doi. 10.1111/j.1365-2125.1992.tb04134.x
- Crewe, HK;
- Lennard, MS;
- Tucker, GT;
- Woods, FR;
- Haddock, RE
- Article
13
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 3, p. 215, doi. 10.1111/j.1365-2125.1992.tb04127.x
- Chalmers, D;
- Whitehead, A;
- Lawson, DH
- Article
14
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 3, p. 275, doi. 10.1111/j.1365-2125.1992.tb04138.x
- Mattie, H;
- Marie, S;
- Slaghuis, G;
- Rozing, PM;
- Strijen, E
- Article
15
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 3, p. 256, doi. 10.1111/j.1365-2125.1992.tb04133.x
- Article
16
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 3, p. 236, doi. 10.1111/j.1365-2125.1992.tb04130.x
- He, GW;
- Shaw, J;
- Yang, CQ;
- Hughes, C;
- Thomson, D;
- McCaughan, B;
- Hendle, PN;
- Baird, DK
- Article